Module

Inherited Susceptibility to Breast Cancer

Source: Breast Cancer Annual Update 2005

Inherited Susceptibility to Breast Cancer


Program Director: Clifford A. Hudis, MD

Faculty:

  • Mark E. Robson, MD

CME CREDIT INFORMATION

Release Date: 10/11/05

Expiration Date: 10/10/06


Physicians: maximum of 1 AMA PRA Category 1 Credit(s)™

Registered Nurses: 1.1 Nursing CE credits

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Distinguish between BRCA1 and BRCA2, the genes most commonly associated with hereditary breast cancer, in terms of prevalence and epidemiology.

  • Evaluate the risk of cancer and potential clinical impact conferred by each gene.

  • Review management of breast cancer risk in unaffected women who carry BRCA1 and BRCA2.


Content includes:

  • Prevalence and Epidemiology of BRCA Mutations
  • Genetic Risk of Cancer
  • Management of BRCA-Associated Cancer
  • Management of Unaffected Women Carrying BRCA1 or BRCA2 Mutations
  • Breast Cancer Screening for Women Carrying BRCA1 or BRCA2 Mutations
  • Nonsurgical Approaches to Reduce Breast Cancer Risk
  • Risk of Ovarian Cancer in Women with BRCA1/BRCA2
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.